The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells.
about
Interaction of Src and Alpha-V Integrin Regulates Fibroblast Migration and Modulates Lung Fibrosis in A Preclinical Model of Lung FibrosisSMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cellsSimultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.Signal transduction molecule patterns indicating potential glioblastoma therapy approaches.Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration.TGFβ1 rapidly activates Src through a non-canonical redox signaling mechanism.A specific PTPRC/CD45 phosphorylation event governed by stem cell chemokine CXCL12 regulates primitive hematopoietic cell motilityProteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma.Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".
P2860
Q33551808-7E7C7BEF-C781-412C-A541-96616105D57FQ33556577-655A4DC0-70B1-4777-A5D4-30B69A0B08DBQ33827178-92DB3217-3684-4A7F-B478-87AFB5377FBAQ34606919-7D5E8669-B6F3-4358-9FF9-515386E32E7DQ37360227-87DD80C4-6EE6-4450-AF89-AD435A2F9D07Q38818048-B37414B4-A11A-4A0E-827E-0E859191A13EQ38833693-D293E04E-AD84-41F3-8467-0E19E601C831Q38883049-052C50EE-0EA0-4DF4-BE35-7435F8BA9915Q38920438-0F5B1BAE-2E4B-4FAF-B975-9418BE9D50BFQ39101349-1E57B2C7-6589-4765-A547-A9A4472D7B12Q39540197-D3768A06-2E2F-4A1A-A9A7-B4020D21929EQ41861080-CAFCADE7-02A9-40EA-A973-0E0EC900CEF4Q42317547-FC038302-3D60-4AC5-A88B-3842B38983B1
P2860
The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The Src family kinase inhibito ...... d and primary carcinoma cells.
@en
The Src family kinase inhibito ...... d and primary carcinoma cells.
@nl
type
label
The Src family kinase inhibito ...... d and primary carcinoma cells.
@en
The Src family kinase inhibito ...... d and primary carcinoma cells.
@nl
prefLabel
The Src family kinase inhibito ...... d and primary carcinoma cells.
@en
The Src family kinase inhibito ...... d and primary carcinoma cells.
@nl
P2093
P2860
P1476
The Src family kinase inhibito ...... d and primary carcinoma cells.
@en
P2093
Frank Gieseler
Hendrik Lehnert
Hendrik Ungefroren
Tobias Bartscht
P2860
P2888
P304
P356
10.1007/S00280-012-1904-0
P577
2012-06-15T00:00:00Z